Inflection Point Acquisition Corp. VIII (IPHX) has consummated its initial public offering (IPO). The company sold 28,750,000 units at a price of $10.00 per unit, generating gross proceeds of $287,500,000. This total includes 3,750,000 units issued as a result of the underwriters' full exercise of their over-allotment option.
Each unit consists of one Class A ordinary share and one-third of one redeemable warrant. The Class A ordinary shares and warrants are expected to begin separate trading on The Nasdaq Global Market under the symbols IPHX and IPHXW, respectively, following the closing of the IPO.
Simultaneously with the closing, the company completed the private sale of 8,000,000 private placement warrants. These warrants were sold to the Sponsor and the sole book-running manager, Cohen & Company Capital Markets, at a price of $1.00 per warrant, generating an additional $8,000,000 in gross proceeds. The private placement warrants are identical to the warrants sold in the IPO but include restrictions on transfer until 30 days after the completion of the initial business combination.
On August 27, 2026, Steven Tannenbaum, William J. Liquori, and William Denkin were appointed to the company's board of directors. Mr. Tannenbaum and Mr. Liquori were appointed to the Board's Audit Committee, with Mr. Denkin serving as chair. Mr. Tannenbaum was also appointed to chair the Compensation Committee. The board is now comprised of three classes of directors.
The net proceeds from the IPO and the private placement warrants, totaling $287,500,000, were placed in a U.S.-based trust account. These funds will remain in the trust account until the earliest of the completion of the company's initial business combination or a redemption of public shares, subject to specific exceptions for taxes and working capital.
